Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature
The use of oral poliovirus vaccine in a worldwide scale has led to a 99.9% decrease in annual incidence of wild-type poliomyelitis and the eradication of serotype 2 poliovirus. However, the emergence of vaccine-derived polioviruses (VDPVs) is endangering the eradication program. Patients with combined immunodeficiencies are at increased risk of both vaccine-associated poliomyelitis and prolonged asymptomatic infection with immunodeficiency-associated VDPVs (iVDPVs). Herein, we present a severe combined immunodeficiency patient with prolonged and asymptomatic iVDPV infection. He continued to shed poliovirus during immunoglobulin replacement therapy and cleared the infection following successful hematopoietic stem cell transplantation (HSCT). To explain the efficiency of HSCT in clearing the infection, we reviewed the literature for all reports of HSCT in iVDPV-excreting patients and discussed novel ideas about the role of different immune mechanisms, including cell-mediated interactions, in mounting immune responses against poliovirus infections. This study could provide further insights into the immune mechanisms contributing to the clearance of enteroviral infections.
KeywordsHematopoietic stem cell transplantation poliomyelitis poliovirus vaccine primary immunodeficiency
We thank Ahmad Nejati, Maryam Yousefi, Yaghoob Mollaie, and all the staff members of the Iran National Polio Laboratory and also CDC-Atlanta for performing thorough virologic studies.
This study was done at the Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. The Iran National Polio Laboratory is supported by the Ministry of Health and Medical Education, the World Health Organization, and Tehran University of Medical Sciences.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635. https://doi.org/10.1146/annurev.micro.58.030603.123625.CrossRefPubMedGoogle Scholar
- 5.Minor P. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies. Dev Biol (Basel). 2001;105:75–80.Google Scholar
- 8.CDC. Update on vaccine-derived polioviruses—worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep. 2012;61:741–6.Google Scholar
- 9.Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med. 1994;11(6):426–38.Google Scholar
- 11.Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-eight years of poliovirus replication in an immunodeficient individual: impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015;11(8):e1005114. https://doi.org/10.1371/journal.ppat.1005114.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Robbins FC. Polio. Rochester: BOYE6; 1999.Google Scholar
- 15.Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-Jahi S, Parvaneh L, Mahmoudi S, et al. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014. Emerg Infect Dis. 2016;22(10):1712–9. https://doi.org/10.3201/eid2210.151071.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, et al. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine. 2018;36(13):1711–9. https://doi.org/10.1016/j.vaccine.2018.02.059.CrossRefPubMedGoogle Scholar
- 17.New clinical diagnosis criteria for the ESID Registry. https://esid.org/Working-Parties/Registry/Diagnosis-criteria#. Accessed 12/28/2017.
- 19.Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90. https://doi.org/10.1007/s10875-014-0001-z.CrossRefPubMedGoogle Scholar
- 21.World Health Organization. Polio laboratory manual. 4th ed. WHO/IVB/04.10, 2004. http://www.who.int/iris/handle/10665/68762. Accessed 12/28/2017.
- 22.Aghamohammadi A, Abolhassani H, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S, et al. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Front Immunol. 2017;8:685. https://doi.org/10.3389/fimmu.2017.00685.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Macklin G, Liao Y, Takane M, Dooling K, Gilmour S, Mach O, et al. Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the World Health Organization Registry. Front Immunol. 2017;8:1103. https://doi.org/10.3389/fimmu.2017.01103.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Driss N, Mellouli F, Yahia AB, Touzi H, Barbouche MR, Triki H, et al. Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency. J Clin Microbiol. 2014;52(9):3486–9. https://doi.org/10.1128/JCM.01122-14. CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Oshrine BR, Li Y, Teachey DT, Heimall J, Barrett DM, Bunin N. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood. Biol Blood Marrow Transplant. 2013;19(11):1581–9. https://doi.org/10.1016/j.bbmt.2013.08.003.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Chen X, Hale GA, Barfield R, Benaim E, Leung WH, Knowles J, et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol. 2006;135(4):524–32. https://doi.org/10.1111/j.1365-2141.2006.06330.x.CrossRefPubMedGoogle Scholar
- 32.Cherrier M. Innate lymphoid cells: new players of the mucosal immune response. Med Sci. 2014;30(3):280–8. https://doi.org/10.1051/medsci/20143003016.
- 34.Driss N, Ben-Mustapha I, Mellouli F, Ben Yahia A, Touzi H, Bejaoui M, et al. High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol. 2012;19(10):1684–9. https://doi.org/10.1128/cvi.00293-12. CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Rouzaire P, Mayol K, Viel S, Bienvenu J, Walzer T. Homeostasis of natural killer cells. Med Sci. 2012;28(4):403–8. https://doi.org/10.1051/medsci/2012284018.
- 38.Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, et al. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Investig. 2014;43(3):292–8. https://doi.org/10.3109/08820139.2013.859156.CrossRefGoogle Scholar
- 39.Chiesa R, Gilmour K, Qasim W, Adams S, Worth AJ, Zhan H, et al. Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol. 2012;156(5):656–66. https://doi.org/10.1111/j.1365-2141.2011.08994.x.CrossRefPubMedGoogle Scholar
- 41.MacCallum FO. Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia. Spec Rep Ser Med Res Counc (G B). 1971;310:72–85.Google Scholar
- 44.Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol. 2006;56(2):145–51. https://doi.org/10.1111/j.1600-0897.2006.00409.x.CrossRefPubMedGoogle Scholar